Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
Titel:
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
Auteur:
Mondaca, Sebastian Margolis, Matthew Sanchez-Vega, Francisco Jonsson, Philip Riches, Jamie C. Ku, Geoffrey Y. Hechtman, Jaclyn F. Tuvy, Yaelle Berger, Michael F. Shah, Manish A. Kelsen, David P. Ilson, David H. Yu, Kenneth Goldberg, Zoe Epstein, Andrew S. Desai, Avni Chung, Vincent Chou, Joanne F. Capanu, Marinela Solit, David B. Schultz, Nikolaus Janjigian, Yelena Y.